Lilly and UK Government launch £85 million obesity care innovation programme
13 September, 2025
Lilly’s Jaypirca shows positive results in phase 3 trial
13 September, 2025
FDA approves AJOVY for paediatric migraine prevention
13 September, 2025
Scotland approves zanubrutinib for relapsed mantle cell lymphoma
13 September, 2025
Sever Pharma expands work on ketamine implant with Silo Pharma
13 September, 2025
Moderna wins EU approval for updated COVID-19 vaccine
13 September, 2025
Eisai data shows sustained benefit of lecanemab in early Alzheimer’s disease
13 September, 2025
Microbiotica completes recruitment for phase 1b ulcerative colitis trial
13 September, 2025
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago